Baba Junichi, Kioi Mitomu, Akimoto Kazunori, Nagashima Yoji, Taguri Masataka, Inayama Yoshiaki, Aoki Ichiro, Ohno Shigeo, Mitsudo Kenji, Tohnai Iwai
Department of Oral and Maxillofacial Surgery, Yokohama City University Graduate School of Medi-cine, Yokohama, Japan.
Department of Oral and Maxillofacial Surgery, Yokohama City University Graduate School of Medi-cine, Yokohama, Japan
Anticancer Res. 2018 Nov;38(11):6291-6297. doi: 10.21873/anticanres.12985.
BACKGROUND/AIM: Atypical protein kinase C λ/ι (aPKCλ/ι) is a cell polarity-regulator localized in the tight junction and apical membrane in epithelial cells. Previous studies suggested that aPKCλ/ι overexpression and abnormal localization were involved in tumor progression in several cancers. We investigated the relationship between aPKCλ/ι and oral squamous cell carcinoma (OSCC).
The correlation between the aPKCλ/ι expression and the clinicopathological parameters in 76 OSCC cases was examined using immunohistochemical analyses.
aPKCλ/ι overexpression was observed in 36.8% of cases. aPKCλ/ι expression was more intense in poorly differentiated OSCC and younger patients (<60 years of age). Although expression of aPKCλ/ι was not significantly associated with clinical parameters, the correlation was found between aPKCλ/ι localization and progression-free survival.
This is the first study to assess the association of aPKCλ/ι expression in OSCC with clinical results. Expression and localization of aPKCλ/ι may be involved in the degree of malignancy in OSCC.
背景/目的:非典型蛋白激酶Cλ/ι(aPKCλ/ι)是一种细胞极性调节因子,定位于上皮细胞的紧密连接和顶端膜。先前的研究表明,aPKCλ/ι的过表达和异常定位与几种癌症的肿瘤进展有关。我们研究了aPKCλ/ι与口腔鳞状细胞癌(OSCC)之间的关系。
采用免疫组织化学分析方法检测76例OSCC病例中aPKCλ/ι表达与临床病理参数之间的相关性。
36.8%的病例中观察到aPKCλ/ι过表达。aPKCλ/ι在低分化OSCC和年轻患者(<60岁)中表达更强。虽然aPKCλ/ι的表达与临床参数无显著相关性,但发现aPKCλ/ι的定位与无进展生存期之间存在相关性。
这是第一项评估OSCC中aPKCλ/ι表达与临床结果之间关联的研究。aPKCλ/ι的表达和定位可能与OSCC的恶性程度有关。